Revision history of "Integrated model of new generation cytometry and ultrasequencing to unveil the pathogenesis of acute myeloblastic leukemia and define new response criteria" (Q3139784)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

10 October 2024

  • curprev 09:3509:35, 10 October 2024DG Regio talk contribs 87,020 bytes +3 Changed label, description and/or aliases in pt
  • curprev 09:3509:35, 10 October 2024DG Regio talk contribs 87,017 bytes −15 Set a claim value: summary (P836): O desafio para a cura da leucemia mieloblástica aguda (LMA) passa inevitavelmente pela compreensão dos mecanismos de leucogénese e quimiorresistência. Muitos pacientes com LMA têm uma história de síndrome mielodisplásica (SMD), mas a investigação longitudinal é extremamente complexa. No entanto, um estudo aprofundado dos diferentes subclones da LMA, incluindo populações displásicas e clones residuais após tratamento (doença residual mínima: MRS), a...

22 March 2024

20 December 2023

12 June 2023

10 June 2023

17 August 2022

  • curprev 19:4919:49, 17 August 2022DG Regio talk contribs 85,757 bytes +59,416 Changed label, description and/or aliases in el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl, nl, fr, de, it, es, and other parts: Adding translations: el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl,

16 January 2022

17 December 2021

9 December 2021

2 December 2021

  • curprev 11:5511:55, 2 December 2021DG Regio talk contribs 16,803 bytes +3,031 Created claim: summary (P836): Le défi pour la guérison de la leucémie myéloblastique aiguë (LAM) passe inévitablement par la compréhension des mécanismes de la leucogenèse et de la chimorésistance. De nombreux patients atteints de LAM ont des antécédents de syndrome myélodysplasique (SMD), mais la recherche longitudinale est extrêmement complexe. Cependant, une étude approfondie des différents sous-clones de la LAM, y compris les populations dysplasiques et les clones résidu...
  • curprev 11:5511:55, 2 December 2021DG Regio talk contribs 13,772 bytes +258 Changed label, description and/or aliases in fr: translated_label

12 October 2021

  • curprev 13:0113:01, 12 October 2021DG Regio talk contribs 13,514 bytes +215 Changed label, description and/or aliases in en: translated_label
  • curprev 13:0113:01, 12 October 2021DG Regio talk contribs 13,299 bytes +2,727 Created claim: summary (P836): The challenge for the healing of acute myeloblastic leukemia (AML) goes unavoidably by understanding the mechanisms of leukamogenesis and chemoresistance. Many patients with AML have a history of myelodysplastic syndrome (MDS), but longitudinal research is extremely complex. However, an in-depth study of the different sub-clones of AML, including dysplastic populations and residual clone after treatment (minimum residual disease: MRS), the diffi...

10 October 2021

9 October 2021

7 October 2021